Demyelinating motor Guillain–Barré syndrome following rubella
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Case report.
A 20-year-old man developed weakness without sensory complaints 10 days after rubella. He had fever, typical rubella rash, and suboccipital lymphadenopathy during an epidemic outbreak in his school. Examination showed symmetric weakness of forearm and intrinsic hand muscles, tibioperoneal muscles, and triceps surae (grade 4/5, Medical Research Council scale) and hyperactive tendon reflexes. He could not get up from squatting or walk on heels and toes. Cranial nerves and sensory examination were normal. Serum creatine kinase was normal. Serologic tests revealed immunoglobulin (Ig) G and IgM antirubella. CSF protein content was increased (0.8 g/L). Electrophysiologic examination showed partial motor conduction blocks (CBs) in eight nerves, prolonged distal motor latencies in tibial nerves, and normal sensory conductions even across the sites of CB (figure). EMG of distal muscles of limbs showed reduced recruitment with high frequency discharging motor units. Brain and spinal MRI and median and tibial somatosensory evoked potentials were normal. A diagnosis of Guillain–Barré syndrome (GBS) was made, and the patient was treated with four plasmaphereses with complete recovery in 6 months. On serial electrophysiologic examination, CBs disappeared in 8 to 16 weeks, and abnormal temporal dispersion occurred in four nerves, indicating that demyelination was the pathophysiologic basis (see figure). Sensory conductions remained normal, and fibrillation potentials were not detected through …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Costs and Utilization of New-to-Market Neurologic Medications
Dr. Robert J. Fox and Dr. Mandy Leonard
► Watch
Related Articles
- No related articles found.
Topics Discussed
Alert Me
Recommended articles
-
Articles
Multifocal inflammatory demyelinating neuropathyA distinct clinical entity?R.M. Van den Berg-Vos, L.H. Van den Berg, H. Franssen et al.Neurology, January 11, 2000 -
Articles
Patterns and serial changes in electrodiagnostic abnormalities of axonal Guillain–Barré syndromeA. Hiraga, S. Kuwabara, K. Ogawara et al.Neurology, March 07, 2005 -
Article
Electrophysiologic findings in multifocal motor neuropathyJ. S. Katz, G. I. Wolfe, W. W. Bryan et al.Neurology, March 01, 1997 -
Article
Residual fatigue in Guillain-Barré syndrome is related to axonal lossJudith Drenthen, Bart C. Jacobs, Ellen M. Maathuis et al.Neurology, October 25, 2013